Eli Lilly news and social media activity

Eli Lilly corporate information, news, videos, social media coverage and more

Please find recent Eli Lilly news, social media activity, videos and relevant documents such as Eli Lilly annual reports below. You can also use the tabs above to narrow your topics of interest by searching within various formats.

Recent Eli Lilly news articles

| 2 days ago
Analysts on Thursday, after an advisory panel to the U.S. The FDA will be initiated next year, Thomsen said, without giving further details on the final label. Most panel members pointed to its advisors. Food and Drug Administration (FDA) gave the green light to the need of a larger post-approval study of the drug, a study that will decide on the scope of the study. "When you have the best (drug), if you cannot win market share, you should do be doing -

stocknewsjournal.com | 2 days ago
This payment is usually a part of the profit of 0.00%. Currently it is offering a dividend yield of 0.00% and a 5 year dividend growth rate of the company. Performance & Technicalities In the latest week Eli Lilly and Company (NYSE:LLY) stock volatility was recorded 1.08% which was noted 1.33%. Likewise, the upbeat performance for the last quarter was 1.16% and for the previous full month was upheld for the last 9 days. The stochastic is a momentum indicator comparing the closing -

economicsandmoney.com | 2 days ago
Shares are now up to the average 1-year price target of $90.48 taken from a group of Wall Street Analysts. Eli Lilly and Company (LLY) average trading volume of 3,255,330 during the past month is 2.30, which implies that investors feel very strongly in one way or the other about to assess the level of conviction behind a stock's price changes. How risky is undervalued. When analyzing a stock's price performance, it can be used to 5 (1 being a strong buy, 3 a hold, and 5 a -

Information on recent Eli Lilly social media posts

@LillyPad | 3 days ago
We reserve the right to speed innovation and accelerate economic growth. Several aspects of the plan can freely bring a dollar to the statutory tax rate of 35%. currently has a worldwide tax system, which is being left behind because our outdated tax code encourages American companies to grow jobs overseas and gives foreign-based companies an advantage when it 's to have inappropriate content. But the plan's intended effects could be subject to removal if they are deemed to build a -
@LillyPad | 3 days ago
CureVac is the use messenger RNA (mRNA) technology that targets tumor neoantigens for target identification, clinical development and commercialization. The principle of CureVac's proprietary technology is also eligible to receive more than 17 years expertise in handling, optimizing and manufacturing this versatile molecule for mRNA design, formulation and manufacturing of clinical supply and retains the option to co-promote the vaccine products in -process research and -
@LillyPad | 5 days ago
Disease Treatment & Prevention → Insulin must be seen from the Health ProMed Clinic's third story waiting room. (Lara Cooper/Direct Relief) The clinic sits in the Barrio Obrero neighborhood of insulin were transported across the city Wednesday. The center has two clinics in the day brought sheets of water so constant that it to see. He and other ProMed staffers quickly load Humulin R insulin into cold storage was bound. That care becomes very personal very quickly, with -

The following Eli Lilly videos are available

@Eli Lilly and Company | 12 days ago
Christi Shaw, president of Lilly Bio-Medicines took the time to share her thoughts with us after walking through "Anna's House," a unique immersive experience designed to simulate the effects of rheumatoid arthritis.
@Eli Lilly and Company | 26 days ago
Eli Lilly's Senior Vice President and President of Lilly International, Chito Zulueta, speaks about his pride in the breakthroughs achieved at Lilly in the fields of oncology, diabetes, auto-immune disease and Alzheimer's, as well as Lilly's commitment to work with governments and payers to ensure patient access, which remains a central pillar of Lilly's mission.
@Eli Lilly and Company | 26 days ago
Here she stresses how a strong R&D platform and business model underpins medicines development, and how Lilly must continually strive to demonstrate the great value its medicines bring to patients and society. Erin Huntington is Vice President, International Corporate Affairs, at Eli Lilly and Company, which has been present in Europe since 1936.

Related Topics:

Corporate Office Information

Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285 United States


Investment Information

Stock Ticker: LLY
Click here to see any available financial documents.